MYOS RENS is the owner of Fortetropin®, the first clinically demonstrated natural myostatin reducing agent. Myostatin is a natural regulatory protein, which inhibits muscle growth and recovery. Fortetropin® is manufactured to optimize biological activity, which MYOS RENS believes has the potential to redefine existing standards for muscle health.